Projekt per år
Personlig profil
Biografi
I have an extensive background in experimental studies and physico-chemical characterization of surfaces, interfaces, nanoscale layers and particle materials in close connection to material science, biophysics and nanotechnology. I received my PhD in 1999 from the Department of Physical Chemistry at Åbo Akademi University. After this I worked 10 years at KSV Instruments Ltd/Biolin Scientific Oy, a company providing high-tech, precision analytical instruments for nanoscale study of interfaces. In January 2010 I returned to academia as a senior researcher at University of Helsinki and held an Academy of Finland Research Fellow position between August 2010 - July 2015. In 2018 I obtained a university lecturer position in pharmaceutical technology at University of Helsinki, and since 1.9.2021 I have been appointed as a professor in New Drug Formulations (position shared between University of Helsinki and Åbo Akademi University). I am also a group leader of the Pharmaceutical Biophysics research group at the Faculty of Pharmacy at University of Helsinki and a member of the BioNanoMaterials group at Åbo Akademi University. My main research focus is to utilize model surfaces, living cells, nanoscience and –technology, and various physico-chemical label-free characterization techniques (e.g., surface plasmon resonance, quartz crystal microbalance and time-resolved Raman spectroscopy) and well-established tools in life sciences to improve the mechanistic understanding of drug and nanoparticle action and delivery.
Expertis relaterad till FN:s globala mål för hållbar utveckling (SDG:er)
2015 godkände FN:s medlemsstater 17 globala mål för en hållbar utveckling (SDG:er), för att utrota fattigdomen, skydda planeten och garantera framgång för alla. Denna personens arbete bidrar till följande SDG(:er):
Externa befattningar
Professor, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki
1 sep. 2021 → …
Docent in Pharmaceutical Nanotechnology, Faculty of Pharmacy, University of Helsinki
1 sep. 2020 → …
Fingeravtryck
- 1 Liknande profiler
Nätverk
Projekt
- 1 Aktiv
-
Nordic POP (Patient-Oriented Products)
Rosenholm, J., Zhang, H., Viitala, T., Filppula, A., Salo-Ahen, O., Bobacka, J., Salminen, T. A., Johnson, M., Peltonen, J. & Wang, X.
01/01/18 → 31/12/25
Projekt: Ministerier / Statliga myndigheter och verk
-
Assembly of Bleomycin Saccharide-Decorated Spherical Nucleic Acids
Tähtinen, V., Gulumkar, V., Maity, S. K., Yliperttula, A. M., Siekkinen, S., Laine, T., Lisitsyna, E., Haapalehto, I., Viitala, T., Vuorimaa-Laukkanen, E., Yliperttula, M. & Virta, P., 19 jan. 2022, I: Bioconjugate Chemistry. 33, 1, s. 206-218 13 s.Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review
Öppen tillgångFil5 Nedladdningar (Pure) -
Co‐delivery CPT and PTX prodrug with a photo/thermo‐responsive nanoplatform for triple‐negative breast cancer therapy
Zhou, W., Ma, X., Wang, J., Xu, X., Koivisto, O., Feng, J., Viitala, T. & Zhang, H., 27 dec. 2022, I: Smart Medicine.Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review
Öppen tillgångFil4 Nedladdningar (Pure) -
Biopharmaceutics of topical ophthalmic suspensions: Importance of viscosity and particle size in ocular absorption of indomethacin
Toropainen, E., Fraser-Miller, S. J., Novakovic, D., Del Amo, E. M., Vellonen, K. S., Ruponen, M., Viitala, T., Korhonen, O., Auriola, S., Hellinen, L., Reinisalo, M., Tengvall, U., Choi, S., Absar, M., Strachan, C. & Urtti, A., apr. 2021, I: Pharmaceutics. 13, 4, 452.Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review
Öppen tillgångFil19 Citeringar (Scopus)7 Nedladdningar (Pure) -
Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform
Ylösmäki, E., Ylösmäki, L., Fusciello, M., Martins, B., Ahokas, P., Cojoc, H., Uoti, A., Feola, S., Kreutzman, A., Ranki, T., Karbach, J., Viitala, T., Priha, P., Jäger, E., Pesonen, S. & Cerullo, V., 26 mars 2021, I: Molecular Therapy - Oncolytics. 20, s. 459-469 11 s.Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review
Öppen tillgångFil17 Citeringar (Scopus)11 Nedladdningar (Pure) -
Controlled Monofunctionalization of Molecular Spherical Nucleic Acids on a Buckminster Fullerene Core
Gulumkar, V., Äärelä, A., Moisio, O., Rahkila, J., Tähtinen, V., Leimu, L., Korsoff, N., Korhonen, H., Poijärvi-Virta, P., Mikkola, S., Nesati, V., Vuorimaa-Laukkanen, E., Viitala, T., Yliperttula, M., Roivainen, A. & Virta, P., 16 juni 2021, I: Bioconjugate Chemistry. 32, 6, s. 1130-1138 9 s.Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review
Öppen tillgångFil4 Citeringar (Scopus)12 Nedladdningar (Pure)
Aktiviteter
- 1 Värd för en akademisk besökare
-
Aryane Vigato
Jessica Rosenholm (Värd) & Tapani Viitala (Värd)
1 sep. 2022 → 31 mars 2023Aktivitet: Stå värd för en besökare › Värd för en akademisk besökare